(IXJ) Global Healthcare - Overview

ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 3.652m USD | Total Return: 11.6% in 12m

Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Providers
Total Rating 38
Safety 56
Buy Signal 0.39
Health Category Rotation: -8.9
TER: 0.42%
AUM: 3.65B
Avg Turnover: 9.70M USD
ATR: 1.45%
Peers RS (IBD): 45.8
Risk 5d forecast
Volatility13.2%
Rel. Tail Risk-1.75%
Reward TTM
Sharpe Ratio0.60
Alpha-1.14
Character TTM
Beta0.404
Beta Downside0.452
Drawdowns 3y
Max DD18.14%
CAGR/Max DD0.27

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: IXJ Global Healthcare

IXJ is an Exchange Traded Fund (ETF) that primarily invests in global healthcare companies. The fund allocates at least 80% of its assets to securities within its underlying index, which tracks the performance of healthcare sector companies deemed important to global markets. The healthcare sector is characterized by a diverse range of businesses including pharmaceuticals, biotechnology, medical devices, and healthcare services.

Up to 20% of IXJs assets may be held in futures, options, swap contracts, cash, and cash equivalents. This allows for flexibility in managing the fund and potentially hedging against market fluctuations. Understanding the specific companies and their business models within this ETF can provide deeper insights. Further research on ValueRay can offer detailed analytics on IXJs holdings and their individual performance.

Headlines to Watch Out For
  • Global pharmaceutical sales growth impacts healthcare sector revenue
  • Medical device innovation drives industry expansion
  • Healthcare policy changes introduce regulatory risks
  • Aging global population increases demand for medical services
What is the price of IXJ shares? As of April 15, 2026, the stock is trading at USD 95.43 with a total of 92,935 shares traded.
Over the past week, the price has changed by +1.80%, over one month by +0.16%, over three months by -4.73% and over the past year by +11.56%.
Is IXJ a buy, sell or hold? Global Healthcare has no consensus analysts rating.
What are the forecasts/targets for the IXJ price?
Analysts Target Price - -
External Resources